In this study we report the molecular and biological characteristics of 19 HIV-1 primary isolates obtained in April 1999 from 47 HIV-1-infected individuals living mainly in western Cameroon. Discontinuous portions of gag, pol, and env were amplified by polymerase chain reaction and directly sequenced. Phylogenetic analysis of these sequences showed that all were of HIV-1 group M with the following genotypes: A gag /A pol /A env (n 5 4), A gag /AG pol /AG env (n 5 2), AG gag /A pol /AG env (n 5 1), AG gag /U pol /AG env (n 5 1), AG gag /AG pol /AG env (n 5 6), 
INTRODUCTION

A
MAJOR CHARACTERISTIC of human immunodeficiency viruses (HIV) is their high genetic variability. This led to the classification of HIV-1 into three groups based on nucleotide sequence analyses: M (major), O (outlier), and N (non M/non O). 1 Whereas group M viruses are prevalent globally, group O viruses are found mostly in West-Central Africa and group N has so far been detected only in Cameroon. The most recent nomenclature of HIV-1 divides group M into subtypes A-D, F-H, and J-K, with F further subdivided into subsubtypes F1 and F2. In addition, there are several groups of circulating recombinant forms (CRFs) of HIV-1. 1 CRFs are groups of viruses that are widely distributed and share a common recombinant lineage. Therefore, different parts of the genomes of CRFs commonly belong to different subtypes, with the crossover point(s) in each CRF group defined by the recombination event(s). Most of the CRFs described to date contain a portion of subtype A. 1 The high genetic variability of HIV-1 is due to the low fidelity of the viral reverse transcriptase (RT), which lacks proofreading activity, and to the high virus turnover in vivo (10 9 virions per day). 2 Retroviruses, including HIV-1, contain two RNA strands of positive polarity, which typically are derived from the same parental provirus. 3 Infected cells can simultaneously harbor two different proviruses, therefore allowing one RNA transcript from each provirus to be encapsidated into a single heterozygous virion. Because RT switches templates during reverse transcription, such heterozygous virions can give rise to recombinant progeny. 4 In fact, intersubtype recombination has been shown to account for more than 10% of all isolates identified and recombinant viruses are increasingly reported in areas harboring more than one HIV-1 subtype. [5] [6] [7] Furthermore, intergroup recombination between O and M group viruses has also been reported. 8 The high genetic variability of HIV and its potential for recombination are clearly important for escape from the immune system and also play a major role in the development of resistance against antiretroviral drugs. Various drug resistance mutations have been described for subtype B isolates of HIV-1, depending on the drug regimen used. 9 Some of these mutations have already been observed in drug-naive individuals as well, but their prevalence and potential for resistance development in non-B-type strains of HIV-1 is currently largely unknown. The genetic subtype may influence the biological phenotype of the virus. The early phase of HIV-1 infection is dominated by non-syncytium-inducing (NSI) viruses, which replicate slowly, are macrophage tropic, and use CCR5 as the main coreceptor. 10 Later, a switch often occurs to syncytium-inducing (SI) viruses, which replicate rapidly in lymphocytes and T cell lines, and use CXCR4 as the main coreceptor.
11 Subtype C viruses appear to be different from most other subgroups, however, because virtually all late C-type isolates have been shown to use predominantly CCR5. 12 Several previous studies have reported a high genetic variability of subtypes and different recombinant forms of HIV-1 from the central and northern parts of Cameroon. 6, 13, 14 The aim of this study was therefore to determine the genetic variability, biological phenotype, and coreceptor usage of primary HIV-1 isolates obtained from drug-naive HIV-1-infected individuals mainly in the northwest and southwest provinces of Cameroon. This region lies between central Cameroon, where almost all HIV groups and subtypes have been found, and Nigeria, where only a limited number of HIV-1 subtypes circulate.
MATERIALS AND METHODS
Sample collection, serological testing, and virus isolation
Blood was collected from individuals highly suspected of or known to be infected with HIV in Limbe and Buea (South West Province) (n 5 28), Bamenda (North West Province) (n 5 10), and Yaoundé (Center Province) (n 5 9) after obtaining ethical clearance and informed consent. Blood was screened for HIV antibodies, using an enzyme-linked immunosorbent assay (ELISA; Behring Marburg, Germany), and a larger sample was collected from HIV-positive individuals. Blood samples were stored at 4°C for a maximum of 7 days (Table 2 ) and were later shipped at room temperature to Germany. On arrival peripheral blood mononuclear cells (PBMCs) from these samples were purified on Ficoll gradients (Amersham Pharmacia Biotech, Uppsala, Sweden). After storing an aliquot at 270°C PBMCs were cocultivated with HIV-negative phytohemagglutinin/interleukin-2-stimulated PBMCs or with PM-1 cells, a T cell line that expresses both the CCR5 and CXCR4 coreceptors. 15 Both cultures were maintained by adding growth medium (RPMI 1640 with 10-20% fetal calf serum, 2 mM glutamine, and antibiotics) twice a week and fresh PBMCs once a week to the PBMC culture. Cultures were monitored for cytopathic effects and syncytium formation. Virus growth was analyzed twice weekly, using a capsid-specific antigen capture ELISA. Positive cultures were harvested and the cell-free supernatants and pellets were stored at 270°C for further analyses.
Biological phenotype and coreceptor usage
Biological phenotypes of all isolates were determined on the HTLV-1-transformed cell line MT-2 as described. 16 Briefly, cell-free virus supernatants containing 50 ng of p24 antigen from the primary cultures were used to infect 2 3 10 5 MT-2 cells in a 12-well plate and incubated overnight at 37°C. The MT-2 cells were then washed with phosphate-buffered saline and resuspended in culture medium. MT-2 cultures were tested for capsid antigen production once a week and monitored for syncytium formation three times a week.
Chemokine coreceptor usage was determined by infecting GHOST cells stably expressing one of the human chemokine receptors [CCR1, CCR2b, CCR3b, CXCR4, CCR5, CCR8, BOB, Bonzo, or CX3CR1 (V28)], using cell-free virus supernatants as described. 17 Briefly, GHOST cells were plated at 5 3 10 3 cells/well in 48-well plates and incubated overnight at 37°C. Culture supernatants were removed before addition of cell-free virus supernatant containing 50 ng of p24 antigen and incubated overnight at 37°C. Fresh medium was added to a total volume of 500 ml/well and plates were incubated at 37°C for 3 days. Supernatant was removed and cells were washed, fixed, and immunostained as described. 17 DNA isolation, polymerase chain reaction, and sequence analysis DNA was extracted from cultured lymphocytes or PM-1 cells with a Qiagen (Hilden, Germany) DNA extraction kit as recommended by the manufacturer. The following distinct regions of gag, pol, and env were amplified by nested polymerase chain reaction (PCR): A 778-bp gag region (complete matrix and 59 capsid), a 755-bp pol region (complete protease and 59 reverse transcriptase), and a 678-bp region of env (V3-V5). The primer pairs used for the nested PCR and their hybridization positions in relation to the standard HxB2r isolate are shown in Table 1 . PCR was performed under standard conditions. For long-range PCR amplification of the complete gag-pol region, we used the Expand high-fidelity PCR system (Boehringer, Mannheim, Germany) as recommended by the manufacturer and primers Gag1 (Table 1 ) and SE5119 (CTTAGCTTTCCTTGAAATAT-ACAT, corresponding to positions 5125-5148 in HxB2r).
The amplimers were purified with a QIAquick gel extraction kit (Qiagen). The long PCR product was cloned into a TA vector (Invitrogen, Groningen, The Netherlands). Nucleotide sequences were obtained by direct sequencing of both strands of the PCR products or clones. Sequencing was performed by the fluorescent dye terminator method, using an ABI model 377A automated sequencer (Applied Biosystems, Foster City, CA).
Phylogenetic analysis and drug resistance analysis
Sequence alignment of the gene fragments was done automatically by CLUSTAL X with minor manual adjustments taking into consideration protein-coding sequences. 18 The new se-quences were aligned with the compilation of nonrecombinant and circulating recombinant form (CRF) HIV-1 sequences from the Los Alamos database. Phylogenetic analyses of these sequences were performed by the neighbor-joining method of the CLUSTAL X program. 18 To prevent the possibility of new sequences obscuring the genetic relationships (especially within the subtype A cluster), unknown sequences were phylogenetically analyzed one at a time. During the final analysis, gaps that were introduced in order to create the alignment were stripped. The statistical robustness of the neighbor-joining tree and reliability of the branching pattern were confirmed by bootstrapping (1000 replicates). SIMPLOT version 2.5 was used to perform bootscanning and similarity analyses. 19 Putative protease and reverse transcriptase drug resistance mutations were determined with the Antiviral Drug Resistance Analysis (ADRA) tool from the HIV database. 20 Codons 9-99 of protease and 1-130 of reverse transcriptase were analyzed. The ADRA tool compares the input sequences with sequences of HIV-1 B-type isolates shown to confer resistance to anti-HIV drugs.
RESULTS
Virus isolation
From the 47 blood samples obtained from HIV-infected individuals (most of them tuberculosis patients) from the four cities we derived 19 primary isolates. Eighteen isolates were obtained by coculture with uninfected PBMCs and 1 by coculture with PM-1 cells. The epidemiological and clinical data are given in Table 2 . 21 The cultivation time until first detection of HIV-1 capsid antigen was highly dependent on patient clinical status and isolates from AIDS patients were obtained within a shorter time ( Table 2) . Although we could not clearly determine the reason for the inability to isolate virus from the other 28 samples, the long period between sample collection and culturing and also the shipment conditions (done at room temperature) are the probable reasons for this low success in virus isolation.
Phylogenetic analysis
To extend our knowledge of the distribution of various HIV-1 subtypes that are circulating in western Cameroon, we sequenced discontinuous fragments from the three major structural genes gag, pol, and env of each isolate. Table 2 summarizes the genetic characteristics of these isolates.
Gag sequences: Figure 1A shows a gag neighbor-joining tree of the new isolates compared with HIV-1 reference sequences. The new sequences were distributed among subtypes A, G, and F2. Because of the fragment length (, 700 bp) of the various genes analyzed, distinction of AG-like viruses from others was possible only by looking at individual sequences. In the case of gag, of the 15 isolates that clustered with subtype A, 8 of them subclustered with the reference CRF02.AG strains (bootstrap value, .70%). 22 Three isolates clustered among the reference G strains whereas one was found to be of the newly described subsubtype F2.
pol sequences: Sequences from the protease and 59 region of reverse transcriptase of the 19 isolates were classified into subtypes: A, CRF02.AG, G, F2, and J (Fig. 1B) . Five isolates clustered with subtype A, eight were CRFAG.02-like viruses, and one isolate (99CMLB20) was unclassifiable. The three isolates clustering with G had also been found to be subtype G in gag and 99CMLB33 was found to be F2 in gag and pol.
An interesting finding among the pol sequences was the identification of a subtype J sequence in the protease region of the 99CMLB40 isolate. Studies have also reported protease sub- 23 env sequences: Figure 1C shows a neighbor-joining tree of the V3-V5 region of the envelope gp120 region. The majority of the new isolates clustered among subtype A (14 of 19) with more than half of them being similar to CRF02.AG-like viruses (10 of 14), including isolate 99CMLB20, which was unclassifiable in pol: whereas the A gag , J pol isolate (99CMLB40) was unclassifiable. The three subtype G gag/pol isolates and the subtype F2
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gag/pol isolate were of the same subtype in env. Taken together, we have identified the following forms of HIV-1 in our panel of Cameroonian isolates:
, and a novel A gag /J pro/rt /A int /U env complex recombinant (n 5 1).
Evidence for a novel A/J/A mosaic gag-pol structure in 99CMLB40
Partial gag, pol, and env analyses of the isolate 99CMLB40 indicated it might be an A/J/U recombinant (Fig. 2) . To confirm this and precisely map the cross-over points, we amplified the entire gag-pol region as a single fragment by long PCR, cloned it into a plasmid, and sequenced it. Using the bootscanning method as implemented in the SIMPLOT program, the cross-over sites were identified (Fig. 2B) . The query sequence 99CMLB40 was compared with the supposed parental subtypes A (92UG037.1) and J (SE9280-9). The entire gag region as well as the 39 part of integrase sequences were shown to be subtype A, whereas the protease, reverse transcriptase, and 59 part of the integrase were subtype J (Fig. 2B) . The A/J cross-over point was located at the gag-pol boundary between nucleotides 1490 TEBIT ET AL. 42 and 1510 (counting from the first nucleotide of gag), similar to our observation when the full-length sequence of isolate 99CMBD6 from our panel was analyzed (data not shown) and had been reported previously for other CRF02.AG viruses. 24 The J/A cross-over point lies within the 59 integrase sequence close to the boundary with RT between positions 3690 and 3710, also similar to the A/G cross-over of 99CMBD6. The distinct A/J/A segments in the gag-pol gene of 99CMLB40 were analyzed phylogenetically in relation to other reference sequences ( Fig. 2A) . In the subtype A portions in gag and pol, the novel A/J sequence was more closely related to pure subtype A isolates than to the other recombinant A viruses (Figs  2A and 1A) . The protease-reverse transcriptase region, on the other hand, clustered with the reference J sequences with a high bootstrap value (100%; Fig. 2A ). These findings, which were further confirmed after amplification and sequencing of regions spanning the cross-over points from uncultured PBMCs of this isolate, indicated that subtype A and J viruses are the parental strains of isolate 99CMLB40.
Biological phenotype, coreceptor usage, and V3 loop sequences
The biological phenotype of the primary isolates on MT-2 cells could be predicted on the basis of patient clinical status (Table 2) . Most SI isolates (four of six) were obtained from patients at late stages of AIDS whereas the NSI isolates were all from asymptomatic individuals or patients with AIDS-related complex, with the exception of 99CMLB40.
The biological phenotypes also correlated with coreceptor usage. All isolates were tested for their ability to infect GHOST cells expressing one of the following chemokine receptors: CCR1, CCR2, CCR3, CXCR4, CCR5, V28, Bonzo, or BOB ( Table 2 ). Irrespective of their subtype (genotype), all NSI isolates used CCR5 as their main coreceptor whereas all SI isolates used CXCR4. Three isolates used another coreceptor in addition to either CCR5 or CXCR4 and one SI isolate was found to be multitropic, using CCR5, CXCR4, CCR3, and CCR1. None of the 19 isolates used CCR2, V28, Bonzo, or BOB for entry.
The V3 loop of HIV env has been shown to be important for antibody neutralization, phenotypic changes, and coreceptor usage. 25 The V3 loops of 14 new isolates consisted of 35 amino acids, whereas 2 isolates consisted of either 34 or 37 amino acids and 1 isolate consisted of 33 amino acids (Fig. 3) . The most common hexapeptide sequences at the apex of the V3 loop were GPGQAF and GPGQTF (7 and 6 of 19, respectively), whereas 1 isolate each contained the sequence GPGRAV, GAGQTF, GPGRGF, GPGY.F, GRGQTF, and GPGRKY. Apart from the GPGY and GAGQ motifs all others had been reported from Cameroon. 6, 13, 14 A greater V3 loop sequence heterogeneity was observed among SI isolates.
The net amino acid charge of the V3 loop was previously found to be a determinant of biological phenotype. 26, 27 All our NSI isolates except for one had a net charge of less than 16, whereas all SI isolates had a net charge of 16 or more. Xiao et al. 27 determined a consensus sequence (S/GXXXGPGXXXXXXXE/ D) proposed to be a predictor of CCR5 coreceptor usage. However, only 7 of our 13 NSI isolates contained this consensus sequence. Furthermore, uncharged and negatively charged amino acids at positions 11 and 25 have been determined as predictors of the NSI phenotype and positively charged amino acids in these positions have been determined as predictors of the SI phenotype. 27, 28 Accordingly, the majority of our NSI isolates contained neutral or negatively charged residues in these positions, whereas five of the six SI isolates contained positively charged residues at one of these positions. However, positive charges at position 11 or 25 were also observed in the case of three NSI isolates (Fig. 3) .
Determination of putative drug resistance mutations in protease and reverse transcriptase
Using the same pol sequences as in the phylogenetic analysis we determined the occurrence of variants corresponding to drug resistance mutations in B-type isolates, using the Antiviral Drug Resistance Analysis tool (ADRA). Codons 9-99 of protease and 1-130 of reverse transcriptase was analyzed and polymorphisms were detected in seven positions previously shown to confer drug resistance. Apart from the M36I mutation, which was observed in all isolates, the frequency of other mutations in our panel of isolates was low. Five, six, and eight isolates, respectively, carried three, two, and one alteration in relevant positions. Only two alterations (V106I and V108I) were observed in the reverse transcriptase sequence (data not shown).
DISCUSSION
Genetic variability studies of HIV-1 in Cameroon have so far been limited to the central urban regions around Yaoundé and Douala, where almost all HIV-1 groups and subtypes have been identified. 6, 13, 23 In this study, we determined the molecular and biological characteristics of 19 HIV-1 isolates obtained mainly from western Cameroon. Our study region included the North West and South West Provinces, which lie between central Cameroon, where all HIV subtypes have been obtained, and Nigeria, which shows relatively fewer HIV subtypes. In West and Central Africa subtype A viruses are the most prevalent, with more than 50% clustering with CRF02AG-like viruses. These viruses cluster differently from subtype A viruses originating from East Africa. 29 HIV prevalence studies from some West African countries indicate less variability in the circulating strains. Peeters et al. 30 demonstrated in four main cities of Nigeria the dominance of group M viruses, mainly A, G, and CRF02.AG-like viruses. Our panel of western Cameroonian HIV-1 isolates were all HIV-1 group M with fewer subtypes when compared with previous studies in the central and northern regions of Cameroon. 6, 13, 14 This should, however, be interpreted cautiously because of the relatively small number of study isolates and also because this is the first detailed molecular study of HIV isolates from this region of Cameroon.
Intersubtype recombination occurs mostly in geographic areas where more than one subtype of HIV prevails. This has been shown to be relatively common in Central Africa. 31 Partial sequencing of the env region does not allow detection of recombinant strains, whereas sequence analysis of regions from more than one of the structural genes (gag, pol, and env) increases the probability of determining possible intersubtype recombinants. 31, 32 We therefore analyzed discontinuous portions
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from the three major structural genes of HIV, allowing an estimation of possible nonrecombinant and recombinant strains on the basis of concordant or discordant phylogenies. The CRF02.AG-like strain was found to be the most prevalent subtype in our study, accounting for roughly half of the isolates. Earlier studies of HIV-1 strains from Yaoundé found a similar prevalence and CRF02.AG viruses have also been described as the most prevalent strain circulating in West and Central Africa. 31 The two complete subtype J sequences currently available in the HIV database have been obtained from the Democratic Republic of Congo (Zaire), 1 but studies have shown the spread of J sequences embedded in subtype A, G, and I sequences from Burkina Faso and other parts of West Africa and, more recently, also from Yaoundé. 23, 31 Unlike the complex mosaic structure of an A/J/? strain from Botswana, 33 the pol gene of 99CMLB40 from this study is almost entirely of subtype J. Generally, the 99CMLB40 sequence showed a different pattern of clustering in the gag-pol region in relation to other J recombinants (A/J/?, A/G/J, and A/G/J/I), suggesting different ancestral recombination events. 34 All subtype G viruses that have been completely sequenced so far contain portions that are either unclassified or subtype A, 7 whereas the subtype G isolates obtained in our panel were complete G at least in the regions sequenced. Pure subtype G sequences are required to define the parental forms of the dominant CRF01.AG circulating in West and Central Africa. 7 Subtype F viruses were reclassified into subtype K and subsubtypes F1 and F2. 1 These viruses, which have been predominantly reported in Cameroon with prevalence rates ranging between 7 and 17%, are also present in other parts of Africa, South America, and Europe. 6, 13, 30 To date most studies of drug resistance/susceptibility have been done with HIV-1 subtype B isolates, which are rarely observed in Africa. Currently, few sequence data are available for the protease and reverse transcriptase genes of nonsubtype B isolates, but some subtype G and F viruses have been shown to be less susceptible to respective inhibitors. 35 The isolates described in this study were obtained from drug-naive HIV-infected individuals. None of the amino acid alterations observed has been shown to directly cause drug resistance. The protease M36I exchange has been associated with inhibitor resistance in the presence of additional mutations. 9 This M36I mutation, which contributes to nelfinavir and ritonavir resistance, appears to occur frequently among non-B isolates and Cornelissen et al. 36 also found a high prevalence of the M36I substitution (71%) in a panel of subtype A-D isolates.
Several studies have shown a broadening of the coreceptor usage profile of HIV-1 isolates associated with progression to AIDS and about 50% of viruses derived from AIDS patients showed usage of multiple coreceptors. 37 In a study to determine coreceptor usage among pregnant women in Cameroon, TEBIT ET AL. 46
FIG. 3.
Relationships between V3 loop amino acid sequences, biological phenotype, and coreceptor usage of Cameroonian HIV-1 primary isolates. Seq. ID, Sequence identity; dot (.), deletion in the amino acid sequence; dash (-), amino acid identity; Ph, biological phenotype; Co-rec., coreceptor; boldface, amino acid positions determining biological phenotype; boldface italics, apex of V3 loop.
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